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ABSTRACT
Affinity Purification of Bovine Lactoferrin and Bovine Transferrin
from Using Immobilized Gangliosides

by

Seung-Hee Nam, Master of Science
Utah State University, 2000

Major Professor: Dr. Marie K. Walsh
Department: Nutrition and Food Sciences
Bovine lactoferrin (BLF) and bovine transferrin (BTF) are major-iron transport
and regulation proteins found in bovine whey. BLF and BTF must interact with the
eukaryotic cell surface to mediate their biological function of iron delivery and cellular
functions of inflammatory and immunological modulation. As common components of
the eukaryotic cell surface, gangliosides were used for affinity purification of BLF and
BTF.
Bovine gangliosides were isolated from fresh buttermilk and covalently
immobilized onto controlled-pore glass beads (66 µgig beads). After the matrix was
loaded with whey protein (WPI or WPC), lactoferrin was eluted with 1 M NaCl and
identified by N-terminal protein sequencing. Pretreated whey isolate (1 % wt/vol) showed
the highest lactoferrin purity with 40% among protein sources, and whey protein isolate
(10% wt/vol) showed the highest recovery with 105%.
Bovine transferrin was eluted with sodium phosphate buffers at pH 7 after the
immobilized matrix was loaded with a 2% (wt/vol) whey solution . The ganglioside
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column resulted in a 74.2% recovery of BTF from whey, and the BTF was enriched to
61 % purity after Mono-Q chromatography. Bovine transferrin was identified by SDSPAGE analysis, Western analysis, and isoelectrofocusing. In conclusion, immobilized
gangliosides can be used to purify BLF andBTF from bovine whey .
(81 pages)

v
ACKNOWLEDGMENTS

I owe my deepest gratitude to my mentor, Dr. Marie Walsh, for her continuous
encouragement, guidance, and support as a scientist. I extend my gratitude to my
committee members, Dr. Donald McMahon, and Dr. Daren Cornforth, for their help and
advice. I am especially thankful to Dr. Rarnrathna Koka in Chicago for helping me as a
friend and a scientific advisor. I gratefully acknowledge financial support received from
the Western Dairy Center and the Dairy Research and Development Corporation .
My friends at "the Walsh lab" are deeply appreciated for all their help and
intellectual discussion. I would like to thank father , mother, my brothers, Kwan-Woo
and Hang-Woo, and my little sister , Hee-Jung . Finall y, this degree could not have been
completed without the encouragemen t and enduring love of my fiance in Missouri ,
Kwang-Yeol Yang.
Seung-Hee Nam

Vl

CONTENTS

Page
ABSTRACT ..................................................................................................................

iii

ACKNOWLEDGMENTS ............ ................. .............................................................

..... v

LIST OF TABLES .......................................................................................................

viii

LIST OF FIGURES ........................................................................................................

ix

LIST OF SYMBOLS, NOTATION, DEFINITIONS ................ ..................... ................. xi
CHAPTER
I

INTRODUCTION ........................ ........... ...... .............. ........ ....... ..... ........... ..... .... 1

II

LITERATURE REVIEW ....................................................................................

3

BIO ACTIVE PROTEINS IN BOVINE WHEY ........ ............................... 3
GANGLIOSIDES ........................... ............... .............. ........... ................. 6
Structure , Distribution, and Function ..... .... ............ ..... ........ .......... 6
Purification ...................................................................................
8
LACTOFERRIN ......................................................................................

9

Structure and Function ............................................. ................. .... 9
Purification ...................................................................................
9
TRANS FERRIN ....... ........ ................ ........... ..... ......... ........ ........... ......... 11
Structure and Function ....... ............... ..................... ................. .... 11
Purification ............. ...... ..................... .......... ............. ........... ....... 11
PROSAPOSIN ....................................................... .............. ......... ......... 12
HYPOTHESIS ................... ..................................................... ............... 14
OBJECTIVES .................... ............... ...... .............................. ................. 14
REFERENCES ............................ ........ ........... ....... ............ ....... ............. 15
III

AFFINITY PURIFICATION OF BOVINE LACTOFERRIN
FROM WHEY ........ ............. ....................... ..................... .............. ......... ....... .... 21
ABSTRACT ..........................................................................................
INTRODUCTION .................................................................................
MATERIALS AND METHODS ............................................................

21
21
23

Ganglioside Purification .............................................................
Ganglioside Immobilization ........................................................

23
23

vu
Whey Protein Preparation ..........................................................
. 24
Ganglioside Affinity Chromatography ......................... ............... 24
Protein Concentration .................................................................
25
SDS-PAGE Analysis and Densitometry ...................................... 25
Determination of the N-terminal Amino Acid Sequence ............. 25
RESULTS ...............................................................

............................... 26

Ganglioside Extraction ................................. .............................. 26
Ganglioside Immobilization ........................................................
27
Affinity Purification of Lactoferrin .......................................... ... 28
Estimated Recovery ....................................................................
33
DISCUSSION ................... ....... ....... ....... ................................................ 34
CONCLUSIONS .......... ............................................. .... ......................... 36
REFERENCES ......... ....... ....... ........................... :............................... .... 36

IV

RAPID FRACTIONATION OF BOVINE TRANSFERRIN USING
IMMOBILIZED GANGLIOSIDES .......... ............................ ......... ................ .... 39
ABSTRACT ........... ...... ........... ..... ................... ............. ........................ . 39
INTRODUCTION ............................ ........................ ............. ................ 39
MATERIALS AND METHODS ............................... ....... ..... ................. 41
Starting Material .........................................................................
Ganglioside Extraction ...............................................................
Ganglioside Immobilization ........................................................
Ganglioside Affinity Chromatography ........................................
Con-A Affinity Chromatography ................................................
Anion Exchange Chromatography ..............................................
SDS-PAGE and Western Analysis ..............................................
Isoelectrofocusing .................. .....................................................
RESULTS ...... ........................................................................................

41
41
41
42
42
43
43
44
44

Immobilized Ganglioside ............................................................
44
Transferrin Purification ...............................................................
45
Con-A Affinity Chromatography ................................................ 50
Mono Q Anion Exchange Chromatography ........................... .... . 50
Western Analysis ........................................................................
51
Isoelectrofocusing .........................................................
....... ....... 51
BTF Purification .........................................................................
51
DISCUSSION ........................................................................................
REFERENCES .......................................... .............................................
V

SUMMARY .....................................................................................................

APPENDIX ............ .... ......................................................................

55
57
61

.............. .............. 63

Vlll

LIST OF TABLES

Table

Page

1.

Composition and biological functions of some bioactive proteins
in bovine whey ........... ......... ............................................................................... 4

2.

Gangliosides in bovine milk. ........................... ..................................................... 6

3.

Extraction of gangliosides from fresh buttermilk .............. ....................... ........... 26

4.

Estimated recovery of bovine lactoferrin from various whey samples using
immobilized ganglioside ...... ................................... .......:................................... 32

5.

Bovine transferrin purification ........................................................................... 55

lX

LIST OF FIGURES
Figure

Page

1.

Nonreducing SDS-PAGE analysis of heat-stable protein from 1% whey
protein isolate solution. Arrow designates BLF in whey samples. Whey
samples were collected from the ganglioside column using various buffers .
Approximately 20 µg of protein was loaded for each sample. Lane 1, 1%
whey protein; lane 2, pretreated 1% WPI; lane A, elutant at pH 7; lane B,
elutant at pH 4; lane C, elutant at pH 4 (0.5 M NaCl); lane D, elutant at pH 4
(1.0 M NaCl) ; lanes M, protein standards with molecular mass x 10-3
indicated ............................. ............ ... .............. ................... .... ......... ................. 29

2.

Nonreducing SDS-PAGE analysis of 1% whey protein isolate solution.
Arrow designates BLF in whey samples. Whey samples -were collected
from the ganglioside column using various buffers. Approximately 20 µg
of protein was loaded for each sample. Lanel, 1% whey protein; lane A,
elutant at pH 7; lane B, elutant at pH 4; lane C, elutant at pH 4 (0.5 M NaCl);
lane D, elutant at pH 4 (1.0 M NaCl); lanes M, protein standards with
............ . 30
molecular mass x 10-3 indicated ............................................................

3.

Nonreducing SDS-PAGE analysis of 1% whey protein concentrate solution.
Arrow designates BLF in whey samples . Whey samples were collected
from the ganglioside column using various buffers. Approximately 20 µg
of protein was loaded for each sample. Lane 1, 1% whey protein; lane A,
elutant at pH 7; lane B, elutant at pH 4; lane C, elutant at pH 4 (0.5 M NaCl) ;
lane D, elutant at pH 4 (1.0 M NaCl); lanes M, protein standards with
molecular mass x 10-3 indicated ........ ........ ...... .............. ........ ............................. 31

4.

Nonreducing SDS-PAGE analysis of whey samples from ganglioside
column. Arrows designate BSA (bovine serum albumin), TFs
(bovine transferrin) , and LF (bovine lactoferrin). Lane M , protein molecular
weight marker; lane W, WPI; lanes A, successive elution of proteins at pH 4 ,
1 M NaCl; lanes B, successive elution of proteins at pH 4; lane C,
elution of proteins at pH 7; lane D, elution of proteins at pH 7, 1 M NaCl.. ........ 46

5.

6.

7.

Nonreducing SDS-PAGE ofWPI fraction at pH 7 after Con-A
chromatography . Lane M, protein molecular weight marker; lane W, WPI;
lane C, gangliosides purified WPI fraction at pH 7; lane Cc, sample C after
Con-A purification ..............................................................................................

47

Mono Q anion exchange chromatography of Con-A purified WPI fraction at
pH 7 containing 1 M NaCl. Grey painted sections contain BTF enriched
samples. A 100 µl sample (10 mg/ml) in 20 mM Tris-Cl buffer (pH 7) was
applied to column and eluted with the same buffer containing 1 M NaCl,
at a flow rate of 1 ml/min ...................................................................................

48

Nonreducing SDS-PAGE analysis of HPLC fractions. Arrows designate
enriched BTF in fractions. Lane M, 10 kDa protein ladder; lanes W, WPI;
lane D, gangliosides fraction at pH 7, 1 M NaCl; lanes 1-13, fractions

x
collected from Figure 6 .................................. .................. ......... ........... .............. 49
8.

9.

SDS-PAGE analysis of WPI Mono Q fractions and commercial standards.
Lane PS, prestained protein standard; lane M, 10 kDa protein ladder;
lanes 5, 6 and 7, Mono Q fractions; lane W, WPI; lane BSA , commercial
bovine serum albumin; lane TF, commercial bovine transferrin; lane LF,
commercial bovine lactoferrin .... .................. .... .................................................

52

Western analysis of Mono Q fractions for BTF detection . Lane PS,
prestained protein standard; lanes 5, 6 and 7, Mono Q fractions; lanes 5N, 6N
and 7N, deglycosylated Mono Q fractions .........................................................

53

10.

Isoelectrofocusing analysis of Mono Q fractions at pH 5/8. Lane M,
Isoelectrofocusing standard marker with PI 3.6/9.3; lanes 5, 6 and 7,
Mono Q fractions; lane BSA , commercial bovine serum albumin ; lane BTF ,
commercial bovine transferrin .............................. ............................... ...... ..... ... 54

A-1.

SDS-PAGE of purified whey samples. All samples are in nonreducing
condition but samples in lanes lR and 7R. Lanes lR and 7R, preparative
electrophoresis purified fractions under reducing condition; lanes 1 and 7,
preparative electrophoresis purified fractions; lane C, elution of proteins at
pH 7 from gangliosides column; lane Cc, Con A fraction of lane C sample;
lane M, protein standard marker. .......... ......... ............ ............ ............... .............. 67

A-2 .

Western analysis of preparative electrophoresis purified whey sample.
Lanes 1-7, preparative electrophoresis purified whey samples were western
analyzed using human anti-saposin C antibody; lane PS, prestained protein
standard marker; lane M, protein standard marker. .............................................

68

LIST OF SYMBOLS,NOTATION,DEFINITIONS
Abbreviation Key
a-LA=alpha lactalbumin
~-LG=beta lactoglobulin
BLF=bovine lactoferrin
BSA=bovine serum albumin
BTF=bovine transferrin
Con-A=concanavalin-A
CPG=controlled pore glass
EDC=carbodiimide
HPLC=high performance liquid chromatography
IEF=isoelectrofocusing
LF=lactoferrin
MFGM=milk fat globule membrane
OPA=O-phthaldialdehyde
Pl=isoelectric point
PP3=proteose peptone
PVDF=polyvinylidene difluoride
SDS-PAGE=sodium dodecyl sulfate-polyacrylamide gel electrophoresis
TF=transferrin
WPC=whey protein concentrate
WPl=whey protein isolate

CHAPTER I
INTRODUCTION
Besides nutritional roles as amino acids, whey proteins in milk have functional
roles such as iron-binding proteins, antibacterial agents, immunoglobulins, growth
factors, vitamin-binding, and enzymes. Major whey proteins include immunoglobulins,
a-lactalbumin, ~-lactoglobulin, and bovine serum albumin. The minor proteins include
lactoferrin, lactoperoxidase, transferrin, proteose-peptones, prosaposin, growth factors,
vitamin-binding proteins, and enzymes. During recent decades, the identification of
minor whey components for functional and nutritional applications has greatly increased.
Among the minor components of whey , bovine lactoferrin (BLF) and bovine
transferrin (BTF) are well-known bioactive proteins, which are found at concentrations of
20 to 200 µg/ml in bovine milk. Each of the two proteins has a major role in iron
metabolism. Bovine lactoferrin is an iron-sequestration protein and bovine transferrin is
an iron-transport protein (43). Bovine lactoferrin and bovine transferrin transport iron
from the biological fluids into the cytoplasm via plasma membrane by receptor-mediated
endocytosis (44). Due to ubiquitous iron requirements, the cell receptors for both
proteins have been observed in a wide range of eukaryotic species and cell types.
Besides its role as an iron transporter, BLF shows multifunctional roles such as
antimicrobial activity, immunomodulatory activity, regulation of myelopoiesis, cellular
growth promotion, and antioxidant effects (55).
In order for BLF and BTF to mediate the biological function of iron delivery and

cellular functions such as inflammatory and immunological reactions, they must interact
with the eukaryotic cell surface. Gangliosides are common components of eukaryotic
cell surfaces.
Current purification procedures for BLF and BTF produce low recovery due to
the co-purification of other proteins. Some methods lead to bjgh purification efficiency,
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but there are multiple steps. Bovine lactoferrin and bovine transferrin have been
purified from complex sources such as milk, serum, and plasma. This research studied
the development of an affinity chromatography technique using immobilized
gangliosides, common components of eukaryotic cell surface, for the purification of BLF
and BTF. Commercially available bovine whey protein concentrate (WPC) and whey
protein isolate (WPI) were used for this study.
This affinity me_thod presents several economic advantages in comparison with
others. This procedure provides efficient isolation and enrichment of highly purified
BLF and BTF. The inclusion of pH and ionic strength differences in the chromatography
buffers removes some of the nonspecifically absorbed whey proteins before elution of
BLF and BTF. Gangliosides coupled to CPG beads have good mechanical properties
which are stable to organic solvents, acidic solutions, and drying . The immobilized
ganglioside column has been used repeatedly without apparent decrease in binding
capacities of BLF and BTF for 6 to 12 months. The support can be cleaned in ethanol,
urea, or high salt buffers.
Chapter ill outlines the affinity purification of BLF using the immobilized
ganglioside matrix from various whey sources. Chapter IV describes the fractionation of
BTF using the immobilized ganglioside matrix from WPI. Bovine transferrin was further
purified by Concanavalin-A sepharose and Mono-Q anion exchange chromatography. In
the Appendix, the details of the purification of bovine prosaposin from whey are
described.
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CHAPTER II
LITERATURE REVIEW

BIOACTIVE PROTEINS IN BOVINE WHEY
Whey proteins in milk have nonnutritional roles such as iron-binding,
antibacterial agents , irnmunoglobulins, growth factors, vitamin binding , and enzymes.
Major components include irnmunoglobulins, a-lactalbumin , ~-lactoglobuln , and bovine
serum albumin . Minor components include lactoferrin, lactoperoxidase, transferrin ,
proteose-peptones, prosaposin, growth factors , vitamin-binding proteins, and enzymes (8,
33). Table 1 shows the composition and biological functions of the identified bioactive
proteins in bovine whey.
Among the minor components of whey , bovine lactoferrin (BLF) and bovine
transferrin (BTF) are well-known bioactive proteins, which are found at concentrations of
20 to 200 µg/ml in bovine milk . Each of the two proteins plays a major role in iron
metabolism. Bovine lactoferrin is an iron-sequestration protein and bovine transferrin is
an iron-transport protein (43). Bovine lactoferrin and bovine transferrin are 80 kDa
glycoproteins, consisting of a single chain of about 700 amino acids and organized with
two terminal lobes with a high degree of similarity (44) . Although BLF displays
sequence and structural homology with BTF , BLF is unique in terms of its various
locations and multifunctional roles in the body. Bovine lactoferrin is known to interact
with the cell surface of various eukaryotic and bacterial cells, mucosal components, many
biopolymers, and other small molecules. Besides its role as an iron sequester, BLF
shows multifunctional roles such as antimicrobial activity, irnmunomodulatory activity,
regulation of myelopoiesis, cellular growth promotion, and antioxidant effects (55).
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TABLE 1. Composition and biological functions of some bioactive proteins in bovine
whey.
Whey protein

Weight contribution
(g/L of milk)

Major 1
~-lactoglobulin
a-lactalbumin
Bovine serum albumin
Immunoglobulins
Minor 1• 2
Lactoferrin
Transf errin
Lactoperoxidase
Enzymes(> 50)
Proteose-peptone s
Prosaposin
Growth factor s
stimulation
Vitamin-binding proteins

3.2
1.2
0.4
0.8
0.2
0.2
0.03
0.03
~ 1
Trace
Tra ce
Trace

I

De-Wit (8) .

2

Adapted from Lonnerdal et al. (33).

Biological function
(Pro) vitamin A transfer
Lactose synthesis, Ca 2+ carrier
Fatty acid transfer , anticancer
Immune protection , anticancer
Bacteriocid _al, iron absorption
Iron absorption and transport
Antibacterial agent
Health indicators
Opioid activit y
Neurotrophic facto r
Mammalian cell growth
Vitamin bioavailability improvement

5
Bovine lactoferrin and bovine transferrin transport iron from the biological fluids
into the cytoplasm via plasma membrane receptor-mediated endocytosis (44). Bovine
lactoferrin and bovine transferrin interact with specific receptors present in variable
amounts on target cells . Important target cells include the liver, bone marrow, and
muscle. Due to ubiquitous iron requirements, the cell receptors for both proteins have
been observed in a wide range of eukaryotic species and cell types . These receptors have
been found on the surfaces of various eukaryotic cells such as erythroid , reticulocyte,
hepatocyte , placental trophoblast, and macrophage cells (41).
In order for BLF and BTF to mediate the biological function of iron delivery and

cellular functions such as inflammatory and immunological reactions, they must interact
with the eukaryotic cell surface. Gangliosides are common components of eukaryotic
cell surfaces. The surface of mammalian cells contains many types of glycoconjugates,
which include proteins, glycosaminoglycans (heparin, heparin sulfate, and Nacetylneuraminic acid), and glycolipids (gangliosides and cerebrosides). Their biologic
function is thought to be involved in cell growth, differentiation , cell-to-cell interactions,
receptor mediated membrane modulation, and malignancy (3). Glycoconjugates
commonly act as receptors for a variety of compounds including interferon, serotonin, a
variety of pathogenic organisms, and bacterial toxins (3, 28).
Recently, prosaposin has been discussed as another minor bioactive component in
whey. Prosaposin is the precursor of the lysosomal saposin proteins, which are required
for hydrolysis of glycosphingolipids, but is also found in its unprocessed form in milks.
This protein plays a broad role in the development, maintenance, and repair of the
nervous system (21). Hiraiwa et al. (23) have demonstrated that prosaposin displayed a
strong affinity to gangliosides at pH 4.0 with great reduction at neutral pH value.
Bovine lactoferrin, bovine transferrin, and prosaposin as bioactive proteins are of
commercial interest due to medical and nutritional benefits. They could be used in infant
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formulas to strengthen the immune system, specialty dietary formulations to assist iron
absorption , pharmaceuticals to treat harmful bacteria, and personal health items such as
antibacterial toothpaste or anti-microbial cosmetics. For commercial uses, a simple
inexpensive purification of BLF, BTF, and prosaposin is needed.

GANGLIOSIDES

Structure, Distribution, and Function
Gangliosides are glycosphingolipids containing one or more N-acetyl or Nglycosy-neuraminic acid (sialic acid) residues as part of the carbohydrate chain. They are
abundant in the central nervous system , especially in grey matter, but smaller amounts
are also widely distributed in the plasma membranes of a variety of tissue cells .
Gangliosides in bovine milk are derived from the apical membrane of the bovine
mammary secretory cell, which is the source of the milk fat globule membrane (MFGM).
This membrane contains 10 to 25% of the total cellular gangliosides of these cells.
The MFGM has the same ganglioside profile as the mammary gland. The MFGM
contains 90% of the gangliosides in milk, mainly GM2, GM3 (20% of the total
gangliosides), and GD3 (50% of the total gangliosides). Minor gangliosides in milk
include GMl, GDlb, and GD2 (26) (Table 2).

TABLE 2. Gangliosides in bovine milk.
Ganglioside

1

Bovine milk

GMl
GM2
GM3
GD3
GD lb
GD2
1

Adapted from Jensen (26).

1.2 µg/l
700 µg/l
300 µg/l
8.8 mg/l
1.2 mg/1
Trace

7
Total quantities of gangliosides are similar in bovine and human milks but human
MFGM contains more GMl and GM3 but less GM2 and GD3 than does bovine milk
(Table 2).
Huang (24) found a very high concentration of gangliosides in commercially
available buttermilk . When expressed in terms of the weight of gangliosides per gram of
total lipid, the ganglioside concentration in buttermilk exceeded even that in the grey
matter of the brain (10 to 20 mg/L vs. 0.5 mg/kg). The GD3 ganglioside in buttermilk
comprises 85% of total gangliosides and consists of two species, one having mainly C16
and C 18 sphingosine and the other having C22 to C24 fatty acids with C 16 and C 18
sphingosine (18). Takamizawa et al. (58) reported that buttermilk contains 0.92 µM of
lipid bound sialic acid per gram of dry weight (72 mg sialic acid/kg), 80% of which is in
the form of GM3, GD3, and GT3.
Gangliosides consist of a lipid moiety (ceramide) to which is attached an
oligosaccharide chain containing at least one sialic acid residue . Gangliosides are
synthesized on the Golgi apparatus and are predominantly located in the plasma
membrane with their oligosaccharide chain exposed on the cell surface . As the ceramide
portion is too short to span the bilayer, gangliosides appear to be confined to the outer
half of the lipid bilayer. Because of their orientation on the cell surf ace, gangliosides
have been implicated in various recognition phenomena (12). As ubiquitous compounds
in all mammalian cell membranes, gangliosides are known to play important biological
roles. Gangliosides act as receptors for viruses, bacteria, toxins, and other ligands.
Gangliosides are also involved in immunomodulation and cell to cell recognition. Their
significance in neurobiology has been reported because of the importance of
glycospingolipids as tumor-associated antigens (19). Possible roles of gangliosides in
cellular activity have been investigated. GM3, GQlb, and neolacto series gangliosides
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showed stimulation of cell proliferation and differentiation in growth factor receptors,
leukemic cell line, and neuronal cells, respectively (20).

Purification
The classical method used for the isolation of gangliosides involves a
chloroform:methanol extraction, partitioning of the gangliosides into an aqueous upper
phase, and dialysis to remove salts and other water-soluble, low molecular weight
molecules. Another approach to ganglioside isolation is the use of a total lipid extraction
and column chromatography such as DEAE-sephadex, anion exchanger Q-sepharose,
TMAE (trimethylarninoethyl) Fractogel, and Sep-Pak C18 cartridges (19, 38, 64). The
structural analysis of gangliosides is performed by periodate oxidation and gas
chromatography (24).
GMl , GM2, GM3, GM4, GD3, and 9-0-acetyl GD3 gangliosides were purified
from milk, brain, meconium, and malignant melanoma in human (27, 32, 59). Mouse
brain and hepatocytes were used to isolate GMl, GM4, GD la, GDlb, GD3, GTlb, and
GQlb gangliosides (36, 38). As an excellent source, bovine buttermilk has been used
extensively to obtain gangliosides. GD3a and GD3b gangliosides, representing 85% of
total lipid-bound sialic acid, have been isolated using various chromatography methods.
A unique ganglioside, 9-0-acetyl GD3, was isolated in large quantities by a combination
of ion exchange and silica gel column chromatography methods. 0-acetylated
gangliosides, GD3, and GT3 were purified using chloroform/methanol extraction and
chromatography on DEAE-sephadex A-25 and Iatrobeads columns (2, 18, 49).

9
LACTOFERRIN

Structure and Function
Lactoferrin (LF), an 80 kDa iron-binding glycoprotein, is present in all exocrine
fluid such as milk, seminal fluid, tears, sweat, and nasal secretion (47, 63). It is found in
milk at concentrations of 20-200 mg/Land in whey at 0.3 to 3% of total protein (55).
Lactoferrin can bind two Fe 3+ ions with high affinity, with both apo and saturated forms
present in milk (46). Lactoferrin has various functions, which include blocking the
growth of various bacteria , fungi, and protozoa. The ability to chelate iron relates to its
antibacterial property, but other functions are the result of the specific interactions with
target cells including monocytes and macrophages (39). Lactoferrin binds surface
structures found on bacteria , and has been shown to interact with eukaryotic cells (10).
Specifically, lactoferrin has been shown to bind glycosaminoglycans, fibrinogen,
collagen type I, collagen type IV, and laminin. Lactoferrin binding to eukaryotic cells is
independent on its degree on iron saturation, and the interaction is thought to be
electrostatic involving basic amino acids at its NH 2 terminus and sulfated
glycosaminoglycans (63). Lactoferrin also binds specific cell receptor proteins on both
eukaryotic and prokaryotic cells (47). Lactoferrin has roles in cellular immunity
including regulation of antibody and cytokine production (54). Lactoferrin binds to
various types of cells such as rnonocytes/rnacrophages, lymphocytes, intestinal brush
border membranes, neutrophils, and platelets (34, 52).

Purification
Lactoferrin contains a strongly basic region close to the N-terminus that
contributes to the interaction of LF with a variety of anionic biological molecules (63).
The N-terminal stretch of LF contains four consecutive arginine residues which have a
decisive role in the binding of LF to physiologically relevant ligands such as heparin
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(55), bacterial lipopolysaccharide, human lysozyme, and DNA (63). The binding of
LF to immobilized heparin (55) was not influenced by pH or 8 M urea, but did dissociate
in the presence of 1.0 M NaCL The authors concluded the main binding force was
electrostatic interactions between the negatively charged sulfate and carboxyl groups of
heparin and positively charged groups in LF.
The interactions between LF and various anionic biological molecules have been
applied for affinity chromatography or ion exchange chromatography. Bovine lactoferrin
was easily purified using 5'-p-aminophenylphosphoryl, uridine 2'-3'-phosphate agarose
(57), or aminohexyl-divinylsulfonyl agarose as affinity chromatographic methods (25).
However, these affinity chromatographic methods needed further purification steps to
separate BLF from co-purifying proteins. Purification methods using ion-exchange
chromatography have been used to purify BLF and BLF peptides (48) . Hydrophobic
interaction chromatography followed by carboxymethyl ion-exchange chromatography
was used to purify BLF and bovine lactoperoxidase from acid whey. This purification
scheme resulted in 80-88 mg/L of BLF protein (66). To increase the BLF purification
yield, acid whey was pretreated with ammonium sulfate and sodium sulfate to remove
major whey fractions and to concentrate the BLF in whey before being applied to
chromatographic methods (65). Ion-exchange chromatographic methods lead to high
purification efficiency but still have the drawback of requiring multiple steps.
Recently, a one-step ion exchange chromatography procedure has been
demonstrated for bovine lactoperoxidase and BLF using a cation exchange membrane
containing immobilized sulfonic acid moieties (6). Using elution buffers of different
ionic strengths, the purification efficiency was 50% for BLF and 73% for bovine
lactoperoxidase. Other purification methods using cationic exchange membranes have
been patented (4, 62).
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TRANSFERRIN

Structure and Function
Transferrin (TF) is a monomeric glycoprotein of 679 amino acids and has a
relative molecular weight of approximately 80 kDa (15). Transferrin exists mainly in the
serum and interstitial compartments of vertebrates and some invertebrates ( 1, 50).
Transferrin is found at much lower concentration in human milk (< 50 µg/ml) in
comparison to bovine milk (20 to 200 µg/ ml) (53). The principal physiological function
of TF in mammals is to transport ferric irons from sites of absorption to sites of
utilization. Transferrin transports iron from the biological fluids into the cytoplasm via
the plasma membrane by receptor-mediated endocytosis (44). Transferrin interacts with
specific receptors present in variable amounts on target cells. Important target cells
include the liver, bone marrow, and muscle. Due to ubiquitous iron requirements , TF
receptors on the cells have been observed in a wide range of eukaryotic species and cell
types. Transferrin receptors have been found on the surfaces of various eukaryotic cells
such as erythroid, reticulocyte, hepatocyte, placental trophoblast, and macrophage (41).
Necker and Cassman (40) demonstrated that TF receptors are induced in human
lymphocytes by interleukin . Melanoma plasma membrane-associated glycoprotein (p97)
from chondrocytes has been demonstrated to have sequence homology with TF (29).
Transferrin acts as a growth factor in vitro and as an essential component in defined
culture media (51). Transferrin has profound stimulatory effects on the cell proliferation
such as hematopoiesis and metanephric differentiation (11, 56) .

Purification
Structurally, TF consists of two homologous lobes . Each lobe is made up of two
domains containing one specific iron-binding site. These sites require synergistic anion
binding for effective iron binding (42). Anions, physiologically carbonate or bicarbonate,
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bind to cationic side chains in the protein in the immediate vicinity of the metalbinding site and result in metal-anionic molecule-protein ternary complex (5, 17, 42).
The interaction between TF and TF receptors is influenced by pH (9). TF
receptors, at physiologic pH, prefer to bind ferric-TF, resulting in a ferric-TF complex.
The ferric-TF complex is transported to the cell cytoplasm by an undiscovered
mechanism and becomes exposed to the acidic pH of the cell cytoplasm, causing rapid
dissociation of iron. The resulting apo-TF complex is recycled to the neutral pH
compartment, including the cell exterior, and apo-TF on the complex is dissociated from
TF receptors (60, 61).
The interactions between TF and various anionic biological molecules have been
used for affinity chromatography or ion exchange chromatography. Previously, several
methods for TF separation from possum milk (14), porcine serum (13), sheep serum (37),
human serum (67), and bovine serum and plasma (35) have been published. Most
separation methods include several steps, including precipitation with ammonium sulfate,
gel filtration, DEAE ion exchange, Mono-Q anion exchange, Blue sepharose affinity, and
Concanavalin-A affinity separation. These methods produced low recovery and less
purity of TF since there was co-purification of other proteins. Milk, serum, and plasma
as TF sources were expensive and inconvenient to handle. Recently, a single step method
purified human TF with 75% yield by DEAE sphadex from a by-product of the
chromatographic fraction of plasma (51).

PROSAPOSIN
Prosaposin from humans is a 70 kDa glycoprotein and is the precursor for
saposins (spingolipid activator proteins). Prosaposin is proteolytically processed into
mature saposins within lysosomes. Prosaposin exists unprocessed as an integral
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membrane protein, and also as a secreted protein in biological fluids such as seminal
plasma, milk, and cerebrospinal fluids (22, 30). In humans, prosaposin exists in
intracellular form of 66 kDa and extracellular form of 73 kDa due to varying levels of
glycosylation since both forms can be converted to a 50 kDa form by deglycosylation (7,
16). Human prosaposin consists of 525 amino-acid residues and approximately 20%
carbohydrate.
Prosaposin binds various gangliosides tightly and facilitates their transfer from
micelles to membranes (23). Gangliosides, sialic acid containing glycospingolipid, are
enriched in nerve tissue and components of plasma membranes. Human prosaposin was
shown to bind 13 different gangliosides with high affinities in the micromolar range (23).
Prosaposin binds to GMl, GDla, GTlb , and GQlb with the highest affinities. The
binding of prosaposin to gangliosides was pH dependent (optimal pH 4) and occurred
over a wide temperature range (4 °C to 80 °C) and was completed within 3 min of
incubation at room temperature.
Gangliosides have a unique ability to enhance neuronal cell proliferation and
increase number and total length of neurites in neuroblastoma cell lines. Therefore,
prosaposin may play an important role in ganglioside transport during neuronal
differentiation and neuritogenesis (23).
The presence of prosaposin was first investigated in human milk by Western
analysis according to Hineno et al. (21). Kondoh et al. (31) and Hiraiwa et al. (22)
isolated prosaposin using several steps such as ion exchange, size exclusion, Con-A
sepharose, and immunoaffinity chromatography from human milk. Only 16.8% of total
prosaposin in human milk was recovered with these multiple methods .
Recently, prosaposin was also isolated from bovine milk and WPC by Patton et
al. (45). Fresh and commercial whey were rich sources of prosaposin. Prosaposin did
not associate with casein micelles, fat globules, membrane fragments, or somatic cells.
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The heat-stable property of prosaposin was used for purification. A large majority of
the heat-labile whey proteins were precipitated after boiling a solution of WPC. The
heat-stable proteins (a-lactalbumin, BSA, and prosaposin) were subjected to multiple
chromatographic steps as described by Hiraiwa et al. (22). Ion-exchange
chromatography reduced the number and amounts of whey proteins, but also resulted in a
50% reduction of prosaposin . Low yields of prosaposin were obtained by
immunoaffinity chromatography (45). Non-reducing SDS-PAGE analysis was used to
separate two glycoproteins, BSA and prosaposin , since each has the same size (66 kDa).
The authors found that the concentration of prosaposin in bovine milk was about 5-10
mg/L, which is similar to that found in human milk. Prosaposin exists in bovine milk as
well as in milk of other species (human , chimpanzee, rhesus, goat, and rat).

HYPOTHESIS

Bovine lactoferrin and bovine transferrin are major-iron transport and regulation
proteins in vertebrates and in some invertebrates. Bovine lactoferrin and bovine
transferrin must interact with the eukaryotic cell surface to mediate their biological
function of iron delivery and cellular functions of inflammatory and immunological
reactions. Gangliosides are common components of eukaryotic cell surfaces. Therefore,
immobilized gangliosides can be used to purify lactoferrin and transferrin from whey.

OBJECTIVES

1.

To develop an immobilized ganglioside matrix for the affinity purfication of BLF
and BTF. Gangliosides were extracted from buttermilk and covalently linked to
controlled pore glass (CPG) beads.
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2.

To purify BLF using the immobilized ganglioside matrix and study the
purification efficiency of BLF from various whey sources.

3.

To fractionate BTF using the immobilized ganglioside matrix from WPI and
assess the purity of BTF using Con-A sepharose and Mono Q anion exchange
chromatography.
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CHAPTER III
AFFINITY PURIFICATION OF BOVINE LACTOFERRIN FROM WHEY
ABSTRACT
Bovine lactoferrin was purified by affinity chromatography using immobilized
gangliosides . Bovine gangliosides were isolated from fresh buttermilk using a
combination of ultrafiltration and organic extraction. Isolated gangliosides were
covalently immobilized onto controlled-pore glass beads . The immobilized matrix
contained 66 micrograms of gangliosides per gram beads . After loading the matrix with
whey protein isolate or whey protein concentrate (WPI or WPC) , it was washed with
sodium phosphate buffer (pH 7) followed by sodium acetate buffer (pH 4) before elution
of lactoferrin with 1 M NaCl in sodium acetate buffer. Lactoferrin was identified by Nterrninal protein sequencing . From the intensities of the protein bands in SDS-PAGE ,
lactoferrin constituted a minimum of 40% of the total protein in the 1 M NaCl eluted
sample. Pretreated WPI ( 1% wt/vol) showed the highest lactoferrin purity among protein
sources and WPI (10% wt/vol) showed the highest recovery. These results show that
immobilized gangliosides can be used to purify lactoferrin from whey. This affinity
purification procedure is suitable to obtain bovine lactoferrin in large quantities .

INTRODUCTION
Bovine lactoferrin, an 80 kDa iron-binding glycoprotein, is present in all bovine
exocrine fluid such as milk, seminal fluid, tears, sweat, and nasal secretion (1). It is
found in milk at concentrations of 20-200 mg/Land in whey at 0.3 to 3% of total protein.
Bovine lactoferrin can bind two Fe 3+ ions with high affinity with both apo and saturated
forms present in milk (20). Lactoferrin (LF) has various functions, which include
blocking the growth of various bacteria, fungi, and protozoa. The ability to chelate iron
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relates to its antibacterial property, while other functions are the result of the specific
interactions with target cells, including monocytes and macrophages (13). Lactoferrin
binds surface structures found on bacteria, and has been shown to interact with eukaryotic
cells (5). Specifically, LF has been shown to bind glycosaminoglycans, fibrinogen,
collagen type I, collagen type IV, and laminin. Lactoferrin binding to eukaryotic cells is
independent of its degree of iron saturation. The interaction of LF with eukaryotic cells is
thought to be electrostatic involving basic amino acids at its NH 2 terminus and sulfated
glycosaminoglycans on cell surfaces (24 ). Lactoferrin also binds specific cell receptor
proteins on both eukaryotic and prokaryotic cells (15). Lactoferrin has roles in cellular
immunity, including regulation of antibody and cytokine production (19). Lactoferrin
binds to various types of cells such as monocytes/macrophages , lymphocytes, intestinal
cells, neutrophils, and platelets (12, 18).
In order for LF to mediate cellular functions, such as inflammatory reactions, it

must interact with the eukaryotic cell surface. Gangliosides are common components of
eukaryotic cell surfaces. The surface of mammalian cells contains many types of
glycoconjugates, which include proteins, glycosaminoglycans (heparin, heparin sulfate,
and N-acetylneuraminic acid), and glycolipids (gangliosides and cerebrosides). Their
biologic function is involved in cell growth, differentiation, cell-to-cell interactions,
receptor-mediated membrane modulation, and malignancy (2). Glycoconjugates
commonly act as receptors for a variety of compounds, including interferon, serotonin, a
variety of pathogenic organisms, and bacterial toxins (2, 10).
Bovine lactoferrin denatures at temperatures greater than 90 °C, and is stable to
pasteurization temperatures. The iron-saturated form is more thermostable than the apo
form. Paulsson et al. ( 14) demonstrated that both unheated and pasteurized BLF showed
similar antibacterial properties. Bovine lactoferrin is of commercial interest because of
its medical and nutritional benefits.
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In this study we have purified bovine gangliosides from buttermilk and
covalently linked them to a solid support for the affinity purification of BLF . The BLF
recovery from various whey sources is reported.

MATERIALS AND METHODS
Ganglioside Purification
Gangliosides were purified from fresh bovine buttermilk (30% solids, Breaden
Butter, Logan, UT). Buttermilk was diluted 1: 10 with water and ultrafiltrated using a
prep/scale-TFF 2.5 ft2 cartridge membrane with 10 kDa (Millipore, Bedford , MA) to
remove lactose. The efficiency of lactose removal was confirmed with a lactose
enzymatic bioanalysi s kit (Boehringer Mannheim, Indianapolis, IN). Moisture, protein,
minerals , and lipid content of lactose-free buttermilk were determined by oven , Kjeldahl,
ash, and Majonnier , respectively. Lactose-free buttermilk was freeze-dried and
gangliosides were extracted using 20 vol of organic mixture of
chloroform:methanol :water (40:80:30 vol) per gram dry solids (6). The sample was
centrifuged at 11,000 x g, and the supernatant was collected and evaporated under
nitrogen gas. The total amount of gangliosides purified was determined by the periodateresorcinol method using sialic acid as standard according to Jourdian et al. (9).

Ganglioside Immobilization
Controlled pore glass (CPG) beads (2000 A 0 , 120-200 mesh) (Sigma, St. Louis,
MO) were derivatized with 3-aminopropyltriethoxy silane and succinylated with succinic
anhydride according to Walsh and Swaisgood (25). Acetic anhydride (10% by vol) in
acetone was used to cap excess amino groups. Gangliosides were saponified to produce
the lyso-derivative containing a free amino group by the reflux boiling method (22). The
OPA method (0-phthaldialdehyde) as described by Weimer and Oberg (26) was used to
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confirm saponification of gangliosides. The carboxyl matrix was reacted with SulfoNHS (Pierce Chemical Co., Rockford, IL) in 0.01 MMES (pH 6) containing watersoluble carbodiimide (EDC). The lyso-gangliosides, dissolved in MES buffer (pH 6),
were circulated through the Sulfo-NHS matrix to couple via amide bond formation for 12
hat 4 °C using a peristaltic pump. Hydroxylamine (10 mM) was added to quench the
reaction by hydrolyzing any unreacted NHS present. The efficiency of gangliosides
immobilized was determined by measuring the amount of sialic acid on the matrix and
the soluble gangliosides in the immobilization solution as described above.

Whey Protein Preparation

Bovine whey protein isolate (WPI) was obtained from Avenmore West
(Twinfalls. ID), and whey protein concentrate was obtained from Cache Valley Dairy
(Logan, UT). Crude whey protein isolate (WPI) and whey protein concentrate (WPC)
were dissolved in 0.05 M sodium acetate buffer, pH 4, yielding various concentrations
such as 1%, 5% and 10% wt/vol As a pretreated sample, 1% WPI solution (1.5 g) was
heated in boiling water for 5 min followed by centrifugation to precipitate denatured
proteins. The remaining heat stable proteins were concentrated using an Amicon
concentrator (Amicon, Beverly , MA) with a 50 kDa membrane and adjusted to pH 4,
with 1 M sodium acetate (pH 4).

Ganglioside Affinity Chromatography

Immobilized gangliosides (5 ml) were packed into stop-flow columns (Pierce,
Rockford, IL) and equilibrated with 0.05 M sodium acetate buffer (pH 4). Crude and
pretreated whey samples were applied to the column and circulated for 5 min at room
temperature. Lactoferrin was eluted by batch mode using four kinds of 0.05 M buffers in
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order: A= sodium phosphate, pH 7; B= sodium acetate, pH 4; C= sodium acetate, pH 4
containing 0.5 M NaCl; and D= sodium acetate, pH 4 containing 1.0 M NaCL

Protein Concentration
The protein concentration of samples eluting from the ganglioside column was
determined by Bradford assay (Bio-Rad, Hercules , CA) with BSA as the standard.

SOS-PAGE Analysis and Densitometry
Protein samples were analyzed by SDS-PAGE under nonreducing conditions with
10% resolving and 5% stacking discontinuou s gel conditions according to a modified
method of Laemmli (11). Gels were stained for 30 min in Coomas sie brilliant R-250 then
destained in 25% methanol , 5% acetic acid (vol/vol) . Dried gels were analyzed by
densitometry to measure the intensities of the protein bands. Densitometry was
performed on photographic images of dried gels using a scanning laser densitometer and
Imager Quant software.

Determination of the N-Terminal Amino Acid Sequence
After SOS-PAGE analysis of samples, proteins were electro-transferred onto
polyvinylidene difluoride (PVDF) membrane followed by staining with Coomassie blue
R-250. The protein band of interest was cut out of the PVDF membrane and subjected to
amino acid sequence analysis by the Edman degradation procedure using an Applied
Biosystem 4 77 protein sequencer.
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RESULTS
Ganglioside Extraction
The efficiency of ganglioside purification from fresh buttermilk is shown in Table
3. Lactose and proteins were removed from buttermilk to prevent Maillard browning
during saponification. The lactose content was reduced approximately 100-fold after
ultrafiltration (10 kDa membrane) and 1000-fold after both ultrafiltration and organic
extraction. The molecular weight of bovine gangliosides ranges from 1 to 3 kDa,
although they form micelles in aqueous solutions in the range of 200 to 250 kDa. Bovine
gangliosides in fresh buttermilk are integrally associated with the milk fat globule
membrane (MFGM) which are typically greater than 0.2 µM in length (8). Gangliosides
were purified from freeze-dried lactose-free buttermilk powder using a mixture consisting
of chloroform, methanol, and water (6).
TABLE 3. Extraction of gangliosides from fresh buttermilk.
Treatment

Ganglioside
content 2
(g/L)

Lactose
content 3
(mg/L)

Protein
content
(g/L)

Fresh buttermilk 1
Ultrafiltration
Ultrafiltration and
organic extraction

1600.0
1400.0
400.0

6700.0
72.0
6.6

87000.0
4171.0
1.0

1

Control as fresh buttermilk contained 87.9% moisture, 8.7% crude protein, 2.7% lipid,
and 0.365% minerals.

2

Gangliosides content was determined by periodate-resorcinol method.

3

Lactose content was determined by enzymatic bioanalysis kit.
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The gangliosides were soluble in the organic phase, and the proteins and residual
lactose were removed with the water phase. The organic extraction of buttermilk
decreased the gangliosides content by 75%, but also decreased the protein level to 1 mg/L
and the lactose to 6.6 mg/L.
The method used to measure the gangliosides content of buttermilk (9) actually
measures sialic acid, which is part of the sugar moiety of gangliosides. Most of the
MFGM-carbohydrates are covalently bound to both lipids and proteins (8). During the
organic extraction step, the gangliosides content was reduced, but this may result in a loss
of glycosylated proteins. However, Table 3 demonstrates that both ultrafiltration and
organic extraction efficiently removed the lactose and protein from buttermilk , while
concentrating the gangliosides fraction.

Ganglioside Immobilization
Gangliosides were saponified to release the fatty acid resulting in a free amino
group. The extent of saponification was monitored using OPA. There was a 74%
increase in amino groups after saponification. The Sulfo-NHS was used to stabilize the
amine-reactive intermediate that was formed between EDC and the carboxyl groups of
the support matrix. The immobilized ganglioside beads were housed in a column and
washed with 100 bead volumes of 0.05 M sodium phosphate buffer in pH 7, followed by
1 L of the same buffer containing 1 M NaCl to remove noncovalently bound
gangliosides.
Hydroxylamine was added to quench the reaction, which also served to cap the
unreacted carboxyl group to prevent nonspecific protein binding. Determination of CPGbound sialic acid with the resorcinol reaction showed that less than 5% of the lysogangliosides were present in the washing solutions. This result indicates that

28
immobilization efficiency is almost 95%. Covalent immobilization yielded 66
micrograms gangliosides per gram bead.

Affinity Purification of Lactoferrin
Whey protein isolate and WPC were used as sources of BLF since they are
essentially fat-free, devoid of caseins, and commercially available. Pretreated WPI, WPI ,
and WPC were applied to the ganglioside column, and proteins eluting with the different
buffers (A= sodium phosphate, pH 7; B = sodium acetate, pH 4; C =sodium acetate, pH
4 containing 0.5 M NaCl; D = sodium acetate, pH 4 containing 1.0 M NaCl) were
collected. Figures 1, 2, and 3 show the SDS-PAGE analysis under nonreducing
conditions of proteins eluting from the column using the three whey protein sources .
Sodium phosphate, pH 7, and sodium acetate, pH 4, without salts were used as washing
steps to remove nonspecifically bound proteins (Figures 1, 2, and 3, lanes A and B).
Sodium acetate, pH 4, containing 1 M NaCl, was applied to elute BLF (Figures 1, 2, and
3, lanes C and D). A protein of 80 kDa molecular weight appears in samples eluted with
salt (Figures 1, 2, and 3, lanes C and D) from the ganglioside column. N-terminal
sequence analysis revealed that the 80 kDa protein was identical with BLF in the 12 Nterminal amino acids sequenced.
The bovine lactoferrin protein band is not easily visible in the starting sample
(Figures 1, 2, and 3, lanes 1 and 2) or in the washing solutions (Figures 1, 2, and 3, lanes
A and B). Buffers at pH 7 and pH 4 without salts removed some of the nonspecifically
absorbed BSA (66 kDa), ~-LG (18 kDa), and a-LA (14 kDa). Increasing salt
concentrations to 0.5 and 1.0 M NaCl were then used to specifically elute BLF. There
was approximately the same amount of BLF in samples C and D (Table 4), but ,in
general, the BLF in sample D contained fewer co-eluting whey proteins.
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Figure 1. Nonreducing SDS-PAGE analysis of heat-stable protein from 1% whey
protein isolate solution. Arrow designates BLF in whey samples. Whey samples were
collected from the ganglioside column using various buffers . Approximately 20 µg of
protein was loaded for each sample. Lane 1, 1% whey protein; lane 2, pretreated 1%
WPI; lane A, elutant at pH 7; lane B, elutant at pH 4; lane C, elutant at pH 4 (0.5 M
NaCl); lane D, elutant at pH 4 (1.0 M NaCl); lanes M, protein standards with molecular
mass x 10-3 indicated.
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Figure 2. Nonreducing SDS-PAGE analysis of 1% whey protein isolate solution .
Arrow designates BLF in whey samples. Whey samples were collected from the
ganglioside column using various buffers . Approximately 20 µg of protein was loaded
for each sample. Lane 1, 1% whey protein; lane A, elutant at pH 7; lane B, elutant at pH
4; lane C, elutant at pH 4 (0.5 M NaCl); lane D, elutant at pH 4 (1.0 M NaCl) ; lanes M,
protein standards with molecular mass x 10-3 indicated.
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Figure 3. Nonreducing SDS-PAGE analysis of 1% whey protein concentrate
solution. Arrow designates BLF in whey samples . Whey samples were collected from
the ganglioside column using various buffers. Approximately 20 µg of protein was
loaded for each sample. Lanel, 1% whey protein; lane A, elutant at pH 7; lane B, elutant
at pH 4; lane C, elutant at pH 4 (0.5 M NaCl); lane D, elutant at pH 4 (1.0 M NaCl); lanes
M, protein standards with molecular mass x 10-3 indicated.
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TABLE 4. Estimated recovery of bovine lactoferrin from various whey samples using
immobilized gangliosides.
Sources

Starting
samples 1
(mg)

BLF in C2
(%)

BLF in D 3
(%)

Total BLF4
(mg)

Estimated
recovery 5
(%)

Pretreated
WPI (1%)

1500.0

36.1

40.3

4.7

WPI (1%)
WPI (5%)
WPI (10%)

135.0
135.0
135.0

14.2
15.7
28.3

22.4
8.0
38.0

1.53
3.10
4.29

38.0
76.5
105.0

WPC (1%)
WPC (5%)
WPC (10%)

16.5
16.5
16.5

18.5
24.5
20.0

22.8
33.3
30.0

0.33
0.24
0.10

67.3
48.5
20.2

7.0

1

Samples were quantitated by Bradford protein assay (Bio-Rad , Hercules , CA) .

2

Lactoferrin (%) present in sample C.

3

Lactoferrin (%) present in sample D.

4Total amount of lactoferrin was calculated on the basis of% of total protein eluted.
5

Calculation based on a BLF concentration of 3% in whey since bovine milk (lL)
contains 2 mg of BLF among 6 mg of whey protein (20).
Protein fractions from the ganglioside column were analyzed by nonreducing

SDS-PAGE to clearly distinguish BLF (80 kDa) from other whey proteins with a similar
molecular weight that may have been co-purified (28). Lactoperoxidase (78 kDa) and
transferrin (72-76kDa) have similar molecular weights but differ in the number of
disulfide bonds. Therefore, we used nonreducing SDS-PAGE. No lactoperoxidase or
transf errin was detected in purified samples as determined by N-terminal protein
sequencing. Lactoperoxidase is also very heat labile and, therefore, may not have been in
the starting whey protein material.
Whey protein isolate solution (1 %) was pretreated by heat-denaturation,
ultrafiltration, and pH adjustment to remove the major heat-labile whey proteins such as
a-lactalbumin, ~-lactoglobulin, BSA, and immunoglobulins. This resulted in a BLF
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purity of 40% after affinity purification. Although BLF is thermostable under acidic
conditions, particularly at pH 4.0 ( 17), pretreatment may have reduced the amount of
BLF in this sample because the BLF recovery was only 7% (Table 4 ).
Since approximately the same amount of BLF was eluted at salt concentrations of
0.5 to 1 M NaCl, the interaction between BLF and gangliosides appears to be influenced
by ionic strength. The use of 0.5 M NaCl was effective in removing BLF and other
bound whey proteins. There was BLF remaining on the column after this wash, which
was eluted with 1 M NaCL This is clearly shown in lanes D of Figures 1, 2, and 3.

Estimated Recovery
The estimated recovery of BLF among WPI, WPC, and pretreated WPI was
compared in Table 4. BLF was recovered with varying efficiency from 105% to 7%
depending on the whey protein source and concentration. The WPI contained 90%
protein, and the WPC contained 11% protein on a gram basis. Each WPI concentration
tested contained 135 mg protein and each WPC concentration tested contained 16.5 mg
protein. Pretreatment of a 1% WPI solution resulted in a 90% loss in protein content
from 1500 mg to 150 mg.
Bovine lactoferrin is found at a concentration of 0.3% to 3% in whey protein, and
the estimated recovery listed in Table 4 was calculated based on 3% BLF in the whey
protein. Whey protein isolate, 10% and 5%, showed the highest recovery among whey
samples, and pretreated WPI showed the lowest. Whey protein concentrate also proved
to be a valuable source of BLF with recovery ranging from 20% to 67%.
The ganglioside column was packed with 2g glass beads containing 132 µg
immobilized gangliosides. The column capacity was calculated using Avogardro's
number (6.023 xl0 23 molecules), using an average ganglioside molecular weight of 1500
g/1 mole and a molecular weight (80,000g/l mole) for BLF in equations (1) and (2).
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132µg x 1 mole x 6.023 xl0
1500 g
5.3 xl0

16

molecules x

23

molecules

=5.3 xl0

16

molecules

(1)

1 mole
1 mole
x 80,000g
23
6.023 xl0 molecules
1 mol

=7.0 x10·

3

g

(2)

In this study, we applied 150 mg whey containing 4.5 mg BLF (3% of whey) to

the ganglioside column, which shows maximum 7 mg or 7.0 x10-3 g BLF binding
capacity . This calculation indicates that the applied sample was not limiting.

DISCUSSION
Bovine lactoferrin contains a strongly basic region close to the N-terminus that
contributes to the interaction of BLF with a variety of anionic biological molecules (24).
The N-terminal stretch of BLF contains four consecutive arginine residues , which have a
decisive role in the binding of BLF to physiologically relevant ligands such as heparin
(20), bacterial lipopolysaccharide, human lysozyme, and DNA (24). The binding of BLF
to immobilized heparin (20) was not influenced by pH or 8 M urea, but did dissociate in
the presence of 1.0 M NaCL The authors concluded the main binding force was
electrostatic interactions between the negatively charged sulfate and carboxyl groups of
heparin and positively charged groups in BLF.
We have shown that BLF interacts with immobilized gangliosides. The
interaction is stable at acidic and neutral pH values, but is influenced by salt
concentration. BLF was eluted from the ganglioside column with both 0.5 and 1 M
NaCL This interaction is eletrostatic and may involve the negatively charged Nacetylneuraminic acid groups in gangliosides . This interaction may also be biospecific,
since BLF is known to interact with eukaryotic membranes .
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The interactions between BLF and various anionic biological molecules have
been applied for affinity chromatography or ion-exchange chromatography. BLF was
easily extracted using 5'-p-aminophenylphosphoryl, uridine 2'-3'-phosphate agarose
(21), or aminohexyl-divinylsulfonyl agarose as affinity chromatographic methods (7).
However, these affinity chromatographic methods needed further purification steps to
separate BLF from co-purifying proteins.
Purification methods using ion-exchange chromatography have been used to
purify BLF and BLF peptides (16). Hydrophobic interaction chromatography followed
by carboxymethyl ion-exchange chromatography was used to purify BLF and bovine
lactoperoxidase from acid whey . This purification scheme resulted in 80-88 mg/L of
BLF (28). To increase the BLF purification yield , acid whey was pretreated with
ammonium sulfate and sodium sulfate to remove major whey fractions and to concentrate
the BLF in whey before applying to chromatographic methods (27). Ion-exchange
chromatographic methods lead to high purification efficiency but still have drawbacks in
requiring multiple steps.
Recently, a one-step ion-exchange chromatography procedure has been
demonstrated for bovine lactoperoxidase and BLF using a cation-exchange membrane
containing immobilized sulfonic acid moieties (4). Using elution buffers of different
ionic strengths, the purification efficiency was 50% for BLF and 73% for bovine
lactoperoxidase. Other purification methods using cationic exchange membranes have
been patented (3, 23).
Our affinity column using gangliosides presents several economic advantages in
comparison with the methods used previously. This affinity chromatography procedure
provides efficient isolation of enriched BLF without the need to pretreat whey.
The inclusion of pH difference in the chromatography buffers removes some of the
nonspecifically absorbed whey proteins before elution of BLF. Gangliosides coupled to
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CPG beads have good mechnical properties and are stable to organic solvents, acidic
solutions, and drying. The immobilized ganglioside column has been used repeatedly
without apparent decrease in BLF binding capacity for 6 to 12 mo. The support can be
cleaned in ethanol , urea, or high salt buffers.

CONCLUSIONS

Bovine lactoferrin was purified by affinity chromatography using immobilized
gangliosides. Our newly developed immobilized gangliosides can be used repeatedly for
a maximum 12 mo with resistance to organic solvents, acidic conditions, and mechanical
pressure. Bovine lactoferrin was efficiently purified using immobilized gangliosides with
0.5-1 M Na Cl. Pretreated WPI ( 1% wt/vol) showed 40% BLF purity among protein
sources, while WPI (10% wt/vol) showed the 105% BLF recovery . This affinity
purification procedure is suitable to obtain BLF in large quantities using inexpensive
commercial whey.
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CHAPTER IV
RAPID FRACTIONATION OF BOVINE TRANSFERRIN USING
IMMOBILIZED GANGLIOSIDES
ABSTRACT
Bovine transferrin (BTF) was fractionated from bovine whey using ganglioside
affinity chromatography.

After loading the immobilized matrix with a 2% whey solution,

the matrix was washed with sodium acetate buffer at pH 4 containingl M NaCl before
elution of BTF with sodium phosphate buffers at pH 7. Concanavalin-A affinity and
Mono-Q anion exchange chromatography were used for further purification. The
ganglioside column showed a 74.2% BTF recovery from whey, and BTF was enriched to
61 % purity with Mono-Q chromatography. Bovine transferrin was identified by SDSPAGE analysis , Western analysis, and isoelectrofocusing. The Concanavalin-A affinity
and Mono-Q anion exchange chromatography steps enriched BTF in the samples and
removed other whey proteins from ganglioside purified fractions. These results indicate
that immobilized ganglioside can be used to fractionate BTF from bovine whey. Our
novel ganglioside affinity is rapid and efficient for BTF fractionation from whey.

INTRODUCTION
Transferrin (TF) is a monomeric glycoprotein of 679 amino acids, with a relative
molecular weight of approximately 80 kDa (11). Transferrin exists mainly in the serum
and interstitial compartments of vertebrates and some invertebrates (2, 23). Transferrin is
found at a much lower concentration in human milk (< 50 µg/rnl) in comparison with
bovine milk (20 to 200 µg/ ml) (25). The principal physiological function of TF in
mammals is to transport ferric irons from sites of absorption to sites of utilization .
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Transferrin transports iron from the biological fluids into the cytoplasm via plasma
membrane by receptor-mediated endocytosis (22). Transferrin interacts with specific
receptors present in variable amounts on target cells. Important target cells include the
liver, bone marrow, and muscle. Due to ubiquitous iron requirements, TF receptors on
the cells have been observed in a wide range of eukaryotic species and cell types.
Transferrin receptors have been found on the surfaces of various eukaryotic cells such as
erythroid, reticulocyte, hepatocyte, placental trophoblast, and macrophage (20). Neckers
and Cossman ( 19) demonstrated that TF receptors are induced in human lymphocytes by
interleukin. Melanoma plasma membrane-associated glycoprotein (p97) from
chondrocytes has been demonstrated to have sequence homology with TF (16).
Transferrin acts as a growth factor in vitro and an essential component in defined culture
media (24). Transferrin has profound stimulatory effects on the cell proliferation such as
hematopoiesis and metanephric differentiation (6, 26).
In order for BTF to mediate the biological function of iron delivery and
stimulatory effects on cell proliferation and differentiation, it must interact with the
eukaryotic cell surface. Gangliosides are common components of eukaryotic cell
surfaces. Gangliosides have been implicated in various recognition phenomena (7).
Gangliosides act as receptors for viruses, bacteria, toxins and other ligands. Gangliosides
also involve in immunomodulation and cell to cell recognition. Gangliosides showed
stimulations of cell proliferation and differentiation in growth factor receptors, leukemic
cell lines, and neuronal cells, respectively (14).
In the present study, we developed a novel ganglioside affinity chromatography
procedure for the fractionation of BTF from whey protein isolate (WPI). The purity of
BTF was increased by Con-A and Mono-Q chromatography, and BTF was identified by
SOS-PAGE analysis, Western analysis, and isoelectrofocusing.
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MATERIALSAND METHODS
Starting Material
Bovine whey protein isolate (WPI) (Avenmore West, Twinfalls, ID) was used as
the source of TF. Whey solution (2% WPI) dissolved in distilled water, was vacuum
filtered through a 0.2 µM membrane filter (Gelman Science, Ann Arbor, Ml) , and stored
at 4 °C. The whey solution was adjusted to pH 4.0 by addition of 1.0 M sodium acetate
at pH 4, just before use .

Ganglioside Extraction
Gangliosides were extracted from fresh bovine buttermilk (Breaden Butter ,
Logan, UT). Buttermilk was diluted 1: 10 with distilled water and ultrafiltrated using a
pre/scale-TFF 2.5 ft2 cartridge membrane with 10 kDa (Millipore, Bedford, MA) to
remove lactose. The efficiency of lactose removal was confirmed with a lactose
enzymatic bioanalysis kit (Boehringer Mannheim, Indianapolis, IN). Lactose-free
buttermilk was freeze-dried and gangliosides were extracted using 20 vol of organic
mixture of chloroform:methanol:water

(40:80:30 vol) per gram dry solids according to

Heitmann et al. (13). The total amount of gangliosides extracted was determined by the
periodate-resorcinol method using sialic acid as standard (15).

Ganglioside Immobilization
Controlled pore glass (CPG) beads (2000 °A, 120-200 mesh) (Sigma, St.Louis,
MO) were derivatized with 3-aminopropyltriethoxy silane and succinylated with succinic
anhydride according to Walsh and Swaisgood (32). Acetic anhydride (10% by vol) in
acetone was used to cap excess amino groups . Gangliosides were saponified to produce
the lyso-derivative containing a free amino group by the reflux boiling method (27). The
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carboxyl matrix was reacted with Sulfo-NHS (Pierce, Rockford, IL) in 0.01 MMES
(pH 6) containing water-soluble carbodiimide (EDC). The lyso-gangliosides, dissolved
in MES buffer (pH 6), were circulated over the Sulfo-NHS matrix to couple via amide
bond for 12 hat 4 °C using a peristaltic pump. Hydroxylarnine (10 rnM) was added to
quench the reaction by hydrolyzing any unreacted NHS present. The extent of
gangliosides immobilized was detennined by measuring the amount of sialic acid in the
supernatant and washing buffers after immobilization (15).

Ganglioside Affinity Chromatography
Immobilized gangliosides were packed into stop-flow columns (Pierce , Rockford ,
IL) and equilibrated with 0.05 M sodium acetate buffer (pH 4) . Whey sample (2% WPI)
was applied to column and circulated for 5 min at room temperature. Bovine transferrin
was purified by batch mode using four kinds of 0.05 M buffers; A= sodium acetate (pH
4), 1 M NaCl; B = sodium acetate (pH 4); C = sodium phosphate (pH 7); D = sodium
phosphate (pH 7), 1 M Na Cl. For the complete removal of lactoferrin and bovine serum
albumin (BSA), the whey sample was applied successively to the ganglioside column and
followed by washing with sodium acetate buffer at pH 4 (buffers A and B) for several
times. Finally, BTF was eluted with sodium phosphate buffer at pH 7 (buffers C and D)
and analyzed by SDS-PAGE under nonreducing conditions.

Con-A Affinity Chromatography
Concanavalin-A sepharose (Con-A) beads (Pharmacia, Uppsala, Sweden) were
packed into disposable polypropylene column (Pierce, Rockford, IL) and equilibrated
with 3 column vol of 10 rnM sodium phosphate (pH 7). The column was loaded with
samples from the ganglioside column after being ultrafiltrated through the 50 kDa
membrane (Amicon, Beverly, MA). The column was washed with 2 column vol of 10
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mM sodium phosphate (pH 7) containing 1.5 M NaCl to remove nonspecifically bound

proteins and glycoproteins were eluted with 1 column vol of 10 rnM sodium phosphate
(pH 7) containing 0.75 M methylmannoside.

Anion Exchange Chromatography
The liquid chromatography system (System Gold Nouveau , Beckman, Fullerton,
CA) consisted of two 125 pumps , a 125 pump-direct controller , a 502 autosampler, and a
168 detector operated at a wavelength of 280 nm. The anion exchange column, Mono-Q
HR 5/5, 5.0 x 50 mm (Pharmacia , Piscataway , NJ), was used with 0.02 M Tris-Cl , pH 7
(buffer A), and the same buffer with 1 M NaCl (buffer B). A stepwise gradient of buffer
B with the following steps was used for BTF separation : 1) 5 ml of 0- 10%; 2) 25 ml of
11-35%; 3) 2 ml of 36-100% ; 4) 2 ml of 100-0%; and 5) 10 ml of 0%. Prior to
chromatography, the Con-A purified whey fractions were filtered through a 0.2-µm
membrane filter (Gelman Science , Ann Arbor, Ml). Buffers were vacuum-filtered
through a 0.2-µM membrane filter (Gelman Science , Ann Arbor , Ml) and degassed
before use .

SDS-PAGE and Western Analysis
To identify BTF among whey proteins in gels, whey factions were resolved by
nonreducing or reducing SDS-PAGE with 10% polyacrylamide according to Laemmli
(17) with modification. One gel was stained with Coomassie blue and destained in 25%
methanol, 5% acetic acid (vol/vol). The dried gel was measured by densitometry to
measure the concentration of BTF in samples . The other gel was electroblotted onto
nitrocellulose membrane as described by Towbin et al. (31). The membrane was blocked
with superblock blocking buffer in TBS (Pierce, Rockford, IL) with gentle agitation for 2
hat room temperature. The membrane was incubated overnight at 4 °C with sheep anti-
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BTF antibody conjugated alkaline phosphatase (Bethyl Lab., Montgomery, TX) in 20
ml of TTBS, diluted 1: 500. Finally, after washing four times with TBS, the blot was
developed by incubation with 10 ml of substrate solution , 1-step NBT /BCIP (Pierce,
Rockford, IL).

Isoelectrofocusing
Isoelectrofocusing (IEF) electrophoresis was carried out vertically at room
temperature using the Mini-protein II electrophoresis cell (Bio-Rad, Richmond , CA).
The anode and the cathode solutions were 7 mM phosphoric acid and 20 mM lysine
containing 20 mM arginin . Proteins were focused at 250 V for 1 hour using a precasted
IEF gel (pH 5/8) (Bio-Rad, Hercules, CA) . The gel was stained with IEF staining
solution (Bio-Rad, Hercules, CA) and destained in 40% methanol, 10% acetic acid
mixture with multiple changes. As standards, BTF, BSA purchased from Sigma
(Stlouis, MO) , and IEF standard (PI 3.5/9.3) (Pharmacia, Piscataway, NJ) were used.

RESULTS
Immobilized Gangliosides
Gangliosides were saponified to release the fatty acid resulting in a free amino
group. These lyso-gangliosides were covalently coupled to succinylated controlled pore
glass (CPG) beads via an amide bond using carbodiimide (EDC) and Sulfo-NHS. The
Sulfo-NHS was used to stabilize the amine-reactive intermediate that was formed
between EDC and the carboxyl group of support matrix. The immobilized gangliosides
beads were housed in a column and washed with 100 bead volumes of 0.05 M sodium
phosphate buffer in pH 7, followed by 1 L of the same buffer containing 1 M NaCl to
remove noncovalently bound gangliosides. Hydroxylamine served to quench the reaction
and cap the unreacted carboxyl group to prevent nonspecific protein binding.
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Determination of sialic acid with the resorcinol reaction showed that less than 5% of
the lyso-gangliosides were present in the washing solutions. This result indicates that
immobilization efficiency is more than 95%. Covalent immobilization yielded 66
micrograms gangliosides per gram bead.

Transf errin Purification

After 2% whey (5 g WPI) in sodium acetate was applied to the ganglioside
column, two protein bands (approximately 76 kDa, 72 kDa) appeared in whey fractions
eluted at pH 7. These protein bands appeared between lactoferrin (80 kDa) and BSA (66
kDa) and had the expected location of BTF (30). These bands were not visible in the
starting sample (Figure 4, lane W). Buffer at pH 4 containing salt (buffer A) removed
lactoferrin and BSA (Figure 4, lanes A). This washing step was carried out after every
application of the same whey sample four times to remove whey proteins. Buffers at pH
7 with (buffer D) and without salt (buffer C) were then applied to specifically elute bound
proteins (Figure 4, lanes C and D). Collected whey fractions were analyzed by
nonreducing SDS-PAGE to clearly distinguish BTF from both lactoferrin and BSA,
which have similar molecular weights within the 60 to 80 kDa range (arrows in Figure4).
Bovine transferrin was eluted with buffers at pH 7 (Figure 4, lanes C and D). After
applying buffer A, the column was equilibrated with buffer B and the eluting sample was
reapplied (Figure 4, lanes A and B). The interaction between BTF and gangliosides was
influenced by pH rather than salt concentration in that BTF was eluted with buffers at pH
7. Prior to eluting BTF from the ganglioside column, multiple washing steps with buffer
A were efficient at removing other whey proteins, especially lactoferrin and BSA.
However, the eluted BTF fraction (Figure 4, lanes C and D) still contained other proteins
including lactoferrin and BSA.
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Figure 4. Nonreducing SOS-PAGE analysis of whey samples from ganglioside
column. Arrows designate BSA (bovine serum albumin) , TFs (bovine transferrin) , and
LF (bovine lactoferrin). Lanes M, protein molecular weight markers; lane W, WPI; lanes
A, successive elution of proteins at pH 4, 1 M NaCl; lanes B, successive elution of
proteins at pH 4; lane C, elution of proteins at pH 7; lane D, elution of proteins at pH 7, 1
MNaCl.
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Figure 5. Nonreducing SDS-PAGE of WPI fraction at pH 7 after Con-A
chromatography. Lane M, protein molecular weight marker; lane W, WPI; lane C,
ganglioside purified WPI fraction at pH 7; lane Cc, sample C after Con-A purification.
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Figure 6. Mono Q anion exchange chromatography of Con-A purified WPI
fraction at pH 7 containing 1 M NaCL Grey painted sections contain BTF enriched
samples. A 100 µl sample (10 mg/ml) in 20 rnM Tris-Cl buffer (pH 7) was applied to
column and eluted with the same buffer containing 1 M NaCl, at a flow rate of 1 ml/min .
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Figure 7. Nonreducing SDS-PAGE analysis of HPLC fractions. Arrows
designate enriched BTF in fractions. Lane M, 10 kDa protein ladder; lanes W, WPI; lane
D, gangliosides fraction at pH 7, 1 M NaCl; lanes 1-13, fractions collected from Figure 6.
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Con-A Affinity Chromatography
An example of Con-A purification on WPI fraction C is shown in Figure 5. Con-

A purification was used to purify the glycoproteins present in lane C of Figure 4. Figure
5 shows that nonglycosylated whey proteins were efficiently removed by Con-A (Figure
5, lane Cc). There are two prominent protein bands at approximatel y 66 kDa, one band at
31 kDa and two bands less than 21 kDa. After Con-A purification, the BTF purity in
samples was increased from 13.9% to 24% .

Mono Q Anion Exchange Chromatography

Con-A purified WPI fraction D was applied to the Mono -Q column and its elution
profile is shown in Figure 6. To assess the purity , the fractions obtained from HPLC
were collected and analyzed by SDS-PAGE under nonreduc ing condition s (Figure 7).
The major protein of fraction 1 has the expected location as lactoperoxidase since it is
known to have faster movement than lactoferrin in SDS-PAGE (33) . Lactoperoxidase is
known to have a physiologically basic PI 9.2 to 9.9 (4) and to be released from positive
column matrix without electrostatic interaction.
Fractions 5, 6, and 7 eluted within 0.1 to 0.15 M NaCl salt have 76 kDa and 72
kDa molecular weights, which correspond to BTF. These protein bands constitute about
64%, 62% , and 57%, respectively , with an average of 61 % of the total protein in SDSp AGE gel. Each of these three factions also contains a 31 kDa molecular weight band ,
expected to be PP3. This band appeared in the ganglioside column fractions (Figure 4 ,
lanes C and D), Con-A fraction (Figure 5, lanes C and Cc), and Mono-Q fractions (Figure
7, lanes 5, 6, and 7). PP3 is lipid-binding glycoprotein present in bovine whey (9).
Interestingly, fraction 9 eluted within 0.15 M to 0.2 M NaCl gradient contained
several whey proteins with molecular weights between 50 kDa and 90 kDa. Anion
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exchange chromatography efficiently separated Con-A purified whey fraction and
increased the BTF purity from 24% to 61 %.

Western Analysis
Whey protein isolate fractions 5, 6, and 7 from Mono-Q chromatography were
analyzed by SDS-PAGE under reducing conditions with BSA, BTF, and lactoferrin as
standards (Figure 8). The location of BTF in the Mono-Q fractions was the same as that
of commercial BTF and one of the two BTF bands showed similar mobility to BSA under
reducing SDS-PAGE conditions. Native-glycosylated and deglycosylated (by Nglycosidase F) samples of the three HPLC fractions were analyzed by Western analysis
using alkaline phosphatase conjugated sheep anti-BTF antibody (Figure 9). On the
Western blot, each fraction (Figure 7, lanes 5, 6, and 7) with and without N-glycosidase F
treatment had two bands recognized by the anti-BTF antibody. These BTF bands were
decreased 2 to 3 kDa molecular mass after deglycosylation (Figure 9, lanes 5N, 6N, and
7N).

Isoelectrofocusing
lsoelectrofocusing (IEF) (Figure 10) showed that only fraction 5 contained pure
BTF bands. The Pis for BTF is 5.8 and 6.0, corresponding to the value obtained for the
standard BTF in Figure 10. Fraction 6 contained two other bands with Pis of 5.5 and 5.7
in addition to the two BTF bands, and fraction 7 contained three other bands with Pis of
5.4, 5.5, and 5.6 as well as one band of BTF. No fraction had BSA, lactoferrin, or
lactoperoxidase.

BTF Purification
Bovine transferrin purification was shown in Table 5. The ganglioside column
was used to fractionate BTF from whey and the Con-A and Mono Q columns were used
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Figure 8. SDS-PAGE analysis of WPI Mono Q fractions and commercial
standards . Lane PS, prestained protein standard ; lane M, 10 kDa protein ladder ; lanes 5,
6 and 7, Mono Q fractions ; lane W, WPI; lane BSA, commercial bovine serum albumin;
lane TF, commercial bovine transferrin ; lane LF, commercial bovine lactoferrin.
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Figure 9. Western analysis of Mono Q fractions for BTF detection. Lane PS,
prestained protein standard; lanes 5, 6 and 7, Mono Q fractions; lanes SN, 6N and 7N,
deglycosylated Mono Q fractions.
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Figure 10. Isoelectrofocusing analysis of Mono Q fractions at pH 5/8. Lane M ,
Isoelectofocusing standard marker with PI 3.6/9.3; lanes 5, 6 and 7, Mono Q fractions ;
lane BSA , commercial bovine serum albumin; lane BTF , commercial bovine transferrin.
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TABLE 5. Bovine transferrin purification.
Total protein 1 Total BTF 2
(mg)
(mg)

Source
2%WPI
Ganglioside column 5
Con-A column 5
Mono Q column 6

5000
801
53
20

5000.0
111.3
12.6
12.2

BTF purity 3

Estimated
recovery 4

(%)

(%)
100.0
74.2

13.9
24.0
61.0

1

Total protein were quantitated by Bradford protein assay (Bio-Rad, Hercules, CA).

2

Total amount of transferrin was calculated on the basis of% of total protein eluted .

3

Densitometry detected transferrin (%) of total protein present

4

ineffluent.

Transferrin is found at a concentration of 3% of total whey protein .

5

WPI fractions at pH 7 with (D) and without salt (C).

6

Fractions 5, 6, and 7 from Con-A purified WPI fraction D.

for further BTF purification. Bovine transferrin is found at concentrations of 3% in whey
protein and the BTF purification listed in Table 5 were calculated based on 3% BTF in
the whey protein (25). The ganglioside column showed 74.2% BTF recovery with 13.9%
purity. The Con-A column and Mono-Q column increased the BTF purity to 24%, 61 %
respectively. The ganglioside column was effective for BTF fractionation from 2% whey
solution (5 g WPI) . The Con-A column and Mono-Q column steps enriched BTF in the
samples and removed other whey proteins from gangliosides purified fractions.

DISCUSSION
Structurally, TF consists of two homologous lobes. Each lobe is made up of two
domains containing one specific iron-binding site. These sites require synergistic anionbinding for effective iron-binding (21). Anions, physiologically carbonate or bicarbonate
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bind to cationic side chains in the protein in the immediate vicinity of the metalbinding site and result in metal-anionic molecule-protein (TF) ternary complex (3, 12,
21).
The interaction between TF and TF receptors is known to be influenced by pH
(5). TF receptors , at physiologic pH, bind ferric-TF, resulting in a ferric-TF complex .
The ferric-TF complex is transported to the cell cytoplasm by an undiscovered
mechanism and becomes exposed to the acidic pH of the cell cytoplasm . This results in a
rapid dissociation of iron. The resulting apo-TF complex is recycled to the neutral pH
compartment, including the cell exterior , and apo-TF on the complex is dissociated from
TF receptor (28, 29).
The interactions between TF and various anionic biological molecule s have been
used for affinity chromatography or ion exchange chromatography. Previously, several
methods for TF separation from possum milk (10), porcine serum (8), sheep serum (18),
human serum (34), and bovine serum and plasma (1) have been published. Most of
separation methods involved several steps, including precipitation with ammonium
sulfate, gel filtration, DEAE ion exchange, Mono-Q anion exchange, Blue sepharose
affinity, and Concanavalin-A affinity separation. These methods produced low
recoveries of TF since there was co-purification of other proteins. Transferrin sources
used are expensive and inconvenient to handle, such as milk, serum, and plasma.
Recently, a single-step method has been demonstrated whereby human TF was purified
with a 75% yield by DEAE spherodex from plasma (24).
In this study, BTF eluting from the gangliosides affinity column contained a

molecular weight heterogeneity of 76 kDa and 72 kDa as shown by SDS-PAGE analysis
and showed two bands with decreased molecular mass after deglycosylation. Transferrin
heterogeneity has been observed only in bovine, but not in human or in rat. This is due to
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the different number of sialyl residues attached to each TF molecule and variant in
cattle (30).
Gangliosides coupled to CPG beads have good mechanical properties resistant for
high pressure, organic solvents, and acidic solutions. The immobilized gangliosides
beads could be repeatedly used for 6 to 12 mo without apparent decrease in BTF binding
capacity if the support is washed with high salt or urea and the immobilized beads are
kept at 4 °C in 0.05% sodium azide .
Transferrin , the iron-binding glycoprotein, is found at much lower concentrations
in human milk (< 50 µg/ml) in comparison to bovine milk (20 to 200 µg/ml ) (25). In this
paper, BTF was fractionated with a high recovery by gangliosides affinity
chromatography using commercial whey.
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CHAPTERV

SUMMARY
Bovine lactoferrin (BLF) and bovine transferrin (BTF) are major-iron transport
and regulatory proteins found in bovine whey. BLF and BTF must interact with the
eukaryotic cell surface to mediate their biological function of iron delivery and cellular
functions of inflammatory and immunological reactions . As common components of
eukaryotic cell surface, gangliosides were used for affinity purification of BLF and BTF.
Bovine ganglios ides were isolated from fresh buttermilk using a combination of
ultrafiltrat ion and organic extraction . Isolated gangliosides were covalentl y immobilized
onto controlled-pore glas s bead s. The immobilized matrix contained 66 microgram s of
gangliosides per gram beads.
The gangliosides affinity technique is a unique and novel method to purify BLF
and BTF. In addition to BLF and BTF , immobilized ganglioside can be used to purify
other proteins that interact with eukaryotic cell walls. This ganglioside affinity method
presents several benefits in comparison with the methods used previously. This affinity
chromatography procedure provides a rapid and efficient isolation of BLF and BTF
without the need to pretreat whey. The inclusions of pH difference and sodium chloride
in the chromatography buffers remove some of the nonspecifically absorbed whey
proteins before elution of BLF or BTF. Gangliosides coupled to CPG beads have good
mechanical properties and are stable to organic solvents, acidic solutions, and drying .
The immobilized ganglioside column has been used repeatedly without apparent decrease
in BLF binding capacity for 6 to 12 mo. The support can be cleaned in ethanol, urea, or
high salt buffers .
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Bovine lactoferrin (BLF) was purified by affinity chromatography using
immobilized gangliosides. After the matrix was loaded with whey protein (WPI or
WPC), the matrix was washed with sodium phosphate buffer (pH 7) followed by sodium
acetate (pH 4) before elution of lactoferrin with 1 M NaCl in sodium acetate buffer.
Lactoferrin was identified by N-terminal protein sequencing. From the intensities of the
protein bands in SDS-PAGE, lactoferrin constitutes a minimum of 40% of the total
protein in the salt eluted sample. Pretreated whey isolate (1 % wt/vol) showed the highest
BLF purity among protein sources, and whey protein isolate (10% wt/vol) showed the
highest recovery of BLF .
Bovine transferrin (BTF) was fractionated from bovine whey using ganglioside
affinity chromatography.

After the immobilized matrix was loaded with a 2% whey

solution, the matrix was washed with sodium acetate buffer at pH 4 containingl M NaCl
before elution of BTF with sodium phosphate buffers at pH 7. Con-A affinity and MonoQ anion exchange chromatography were used for further purification . The ganglioside
column showed a 74.2% BTF recovery from whey and BTF was enriched to 61 % purity
with Mono-Q chromatography. Bovine transferrin was identified by SDS-PAGE
analysis, Western analysis, and isoelectrofocusing.
Bovine lactoferrin and bovine transferrin are of commercial interest because of
their medical and nutritional benefits . Therefore, BLF and BTF purified using our
affinity column could be applied to inf ant formulas to strengthen the immune system, to
specialty dietary formulations to assist iron absorption, to pharmaceuticals to treat
harmful bacteria, and to personal health items such as antibacterial toothpaste or antimicrobial cosmetics.
In conclusion, immobilized gangliosides can be used to purify BLF and BTF from
bovine whey. These affinity purification procedures are suitable to obtain BLF and BTF
from whey.
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AN ATTEMPT AT THE PURIFICATION OF BOVINE PROSAPOSIN
FROM WHEY

INTRODUCTION

Prosaposin is a 66 kDa glycoprotein found in milk at a concentration of 6 µg/ml
(9), contains 20% carbohydrate, and has an isoelectric point of 5.4. (1, 3). Prosaposin is
the precursor of the lysosomal saposin proteins, which are required for hydrolysis of
glycosphingolipids, but is also found in its unprocessed form in milks. This protein plays
a broad role in the development, maintenance, and repair of the nervous system (4, 8).
Hiraiwa et al., (6) have demonstrated that prosapos in displayed a strong affinity to
gangliosides at pH 4.0 a greatly reduced affinity at neutral pH value . Prosaposin in
human milk was isolated using several steps such as ion exchange, size exclusion, Con-A
sepharose, and immunoaffinity chromatography (5, 6). Recently , bovine prosaposin was
isolated from bovine milk and whey protein concentrate (WPC) with multiple steps such
as Con-A sepharose, cellulose anion exchange , and immunoaffinity chromatography (9).
In this study, I tried to purify bovine prosaposin by biospecific binding using

gangliosides affinity chromatography as well as by traditional methods including Con-A
sepharose, Mono Q anion exchange, and isoelectricfocusing.

Approach 1
The interactions between prosaposin and gangliosides were found to be maximal
at acidic pH values and greatly reduced at neutral pH values (6). A 1% solution of WPI
in 50 mM sodium acetate buffer at pH 4 was applied to the immobilized gangliosides
matrix. Prosaposin was purified by batch mode using four different buffers; A=sodium
acetate, pH 4 containing 1 M NaCl; B= sodium acetate , pH 4; C= sodium phosphate, pH
7; D= sodium phosphate, pH 7 containing 1 M NaCl. Whey proteins not bound to the
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column at pH 4 were reapplied to the column after washing the matrix with buffer B.
Lactoferrin (3% of whey) and BSA (10% of whey) are more abundant than prosaposin
(0.1 % of whey) (2, 9, 10). Since BSA and lactoferrin were bound to the matrix, BSA and
lactoferrin were removed at pH 4 with 1 M NaCl before eluting proteins at pH 7 (Figure
1). The eluting proteins were collected and each fraction was analyzed by nonreducing
SDS-PAGE to distinguish prosaposin from BSA, which has a similar molecular weight of
66 kDa (9). Successiv_e elution of proteins at pH 4 containing salt removed a significant
amount of BSA, lactoferrin , ~-lactoglobulin, and a-lactalbumin from the whey sample
(Figure 1, lanes B). Specific elution of proteins at pH 7 with and without salt is shown in
lanes C and D. There is an enrichment in proteins between 80 kDa and 60 kDa which are
not visible in the starting sample (Figure 1, lane W).

Approach 2
Con-A sepharose column was used to purify the protein eluting with buffer C
(which is from the gangliosides matrix) because prosaposin is glycoprotein. Lane Cc in
Figure A-1 shows the glycoproteins present in this sample. The two glycoprotein bands
between BSA and lactoferrin were separated by preparative electrophoresis and subjected
to Western analysis using human anti-saposin C antibody (9) (Figure A-2). Under
reducing conditions, two bands have approximately the same molecular weight, but under
nonreducing condition, they show different mobility (Figure 4). Prosaposin is
immunologically undistinguishable because the saposin C antibody showed
crossreactivity to BSA and lactoferrin as well as prosaposin (Figure A-2). The two bands
were purified by preparative electrophoresis (Figure 4, lanes 1 and 2) and N-terminal
protein was sequenced for identification . The two bands contained several proteins
which showed 80% and 75% homologies with transferrin and ~-lactoglobulin,
respectively. The upper protein band of two bands showed about 75% homology with
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the amino acids of prosaposin. This result suggests that a single band of prosaposin
could not be separated by methods using size difference of protein such as preparative
electrophoresis, size exclusion.

Approach 3
Con-A fraction of elutant at pH 7 (Figure A-1, lane Cc) was applied to Mono Q
anion exchange column for charge separation and collected to analyze by SDS-PAGE
(Figure 5). Anion exchange chromatography resulted in a significant separation of whey
proteins and the enrichment of two bands, which have the expected location of
prosaposin (Figure 5, lanes 5, 6, and 7). Prosaposin is known to convert from 66 kDa to
50 kDa after deglycosylation with N-deglycosidase F (1). Fractions 5, 6, and 7 which
contained mainly two protein bands were deglycosylated with N-deglycosidase F to
distinguish prosaposin from protein mixture with the same molecular weights by
reduction of protein size. Unfortunately, after deglycosylation , the decreased size of
commercial tansferrin was similar to those of the two bands. Native glycosylated and
deglycosylated fractions 5, 6, and 7 were analyzed by SDS-PAGE for irnrnunodetection
using human anti-saposin C antibody . On the Western blot, all samples without and with
treatment by N-deglycosidase F showed weak corresponding to saposin C antibody.
However, this result could not be considered as a meaningful one in that saposin C
antibody crossreacts with transferrin as well as with BSA and lactoferrin. Fractions 5, 6,
and 7 were focused on isoelectrofocusing gel with PI 5/8 for further separation of the
two bands (Figure 6). Fraction 5 contained only transferrin with Pis of 5.8 and 6.0, but
fraction 6 and 7 contained other protein bands including transferrin within PI 5.5 to 6.0
(Figure 6, lanes 5, 6, and 7). The Western analysis of isoelectrofocused was not tried
since unknown proteins in fractions showed PI values similar to each other, and saposin
C antibody did not have special crossreactivity to detect prosaposin.
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Figure A-1. SDS-PAGE of purified whey samples. All samples are in
nonreducing condition but samples in lanes lR and 7R. Lanes lR and 7R, preparative
electrophoresis purified fractions under reducing condition; lanes 1 and 7, preparative
electrophoresis purified fractions; lane C, elution of proteins at pH 7 from ganglioside
column; lane Cc, Con-A fraction of lane C sample; lane M, protein standard marker.
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Figure A-2. Western analysis of preparative electrophoresis purified whey
sample. Lanes 1-7, preparative electrophoresis purified whey samples were western
analyzed using human anti-saposin C antibody ; lane PS, prestained protein standard
marker; lane M, protein standard marker.
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Due to time limitations and the lack of detection equipment for prosaposin,
further investigation was terminated.

Immobilized gangliosides developed from

approach 1 used to purify lactoferrin and transferrin as bioactive proteins, present in milk.
Traditional protein separation methods from approaches 2 and 3 contributed mainly to
isolate transferrin from bovine whey.
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